Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin

Journal of Neurochemistry

Volumn 72, Issue 5, 1999, Pages 1890-1898

  Chen, Nansheng ^a   Luo, Tao ^a   Wellington, Cheryl ^a   Metzler, Martina ^a   McCutcheon, Krista ^a   Hayden, Michael R ^a   Raymond, Lynn A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Excitotoxicity; Glutamate; HEK 293 cells; Huntingtin; Patch clamp

Indexed keywords

CYTOSKELETON PROTEIN; GLUTAMINE; HUNTINGTIN; ION CHANNEL; MUTANT PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBTYPE;

ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; NERVE DEGENERATION; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

CELL LINE; DIZOCILPINE MALEATE; ELECTRIC CONDUCTIVITY; HUMANS; ION CHANNELS; ISOMERISM; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTRATE SPECIFICITY;

SPINY;

EID: 0032971311     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0721890.x     Document Type: Article

References (71)

1. Albin R. L. and Greenamyre J. T. (1992) Alternative excitotoxic hypotheses. Neurology 42, 733-738.
2. Albin R. L., Young A. B., Penney J. B., Handelin B., Balfour R., Anderson K. D., Markel D. S., Tourtellotte W. W., and Reiner A. (1990) Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. N. Engl. J. Med. 322, 1293-1298.
3. Beal M. F., Kowall N. W., and Ellison D. W. (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321, 168-171.
4. Beal M. F., Kowall N. W., Ferrante R. J., and Cippolloni P. B. (1989) Quinolinic acid striatal lesions in primates as a model of Huntington's disease. Ann. Neurol. 26, 137.
5. Béhé P., Stern P., Wyllie D. J., Nassar M., Schoepfer R., and Colquhoun D. (1995) Determination of NMDA NR1 subunit copy number in recombinant NMDA receptors. Proc. R. Soc. Lond. B Biol. Sci. 262, 205-213.
6. Bhide P., Day M., Sapp E., Schwarz C., Sheth A., Kim J., Young A. B., Penney J., Golden J., Aronin N., and DiFiglia M. (1996) Expression of normal and mutant huntingtin in the developing brain. J. Neurosci. 16, 5523-5535.
7. Chen N., Moshaver A., and Raymond L. A. (1997) Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition. Mol Pharmacol. 51, 1015-1023.
8. Choi D. (1996) Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. 6, 667-672.
9. Cooper J. K., Schilling G., Peters M. F., Herring W. J., Sharp A. H., Kaminsky Z., Masone J., Khan F. A., Delanoy M., Borchelt D. R., Dawson V. L., Dawson T. M., and Ross C. A. (1998) Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet. 7, 783-790.
10. Coyle J. T. and Puttfarcken P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
11. Davies S. W., Turmaine M., Cozens B. A., DiFiglia M., Sharp A. H., Ross C. A., Scherzinger E., Wanker E. E., Mangiarini L., and Bates G. P. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
12. Dawbarn D., DeQuidt M. E., and Emson P. L. (1985) Survival of basal ganglia neuropeptide Y-somatostatin neurons in Huntington's disease. Brain Res. 340, 251-260.
13. DiFiglia M. (1990) Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci. 13, 286-289.
14. DiFiglia M., Sapp E., Chase K., Schwarz C., Meloni A., Young C., Martin E., Vonsattel J.-P., Carraway R., Reeves S. A., Boyce F. M., and Aronin N. (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075-1081.
15. DiFiglia M., Sapp E., Chase K., Davies S. W., Bates G. P., Vonsattel J. P., and Aronin N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neuntes in brain. Science 277, 1990-1993.
16. Duyao M. P., Auerbach A. B., Ryan A., Persichetti F., Barnes G. T., NcNeil S. M., Ge P., Vonsattel J. P., Gusella J. F., Joyner A. L., and MacDonald M. E. (1995) Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269, 407-410.
17. Dzubay J. A. and Jahr C. E. (1996) Kinetics of NMDA channel opening. J. Neurosci. 16, 4129-4134.
18. Ehlers M. D., Zhang S., Bernhardt J. P., and Huganir R. L. (1996a) Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit. Cell 84, 745-755.
19. Ehlers M. D., Mammen A. L., Lau L. F., and Huganir R. L. (1996b) Synaptic targeting of glutamate receptors. Curr. Opin. Cell. Biol. 8, 484-489.
20. Glued subunit of dynactin. Hum. Mol. Genet. 6, 2205-2212.
21. Ferrante R. J., Kowall N. W., Beal M. F., Richardson E. P. Jr., Bird E. D., and Martin J. B. (1985) Selective sparing of a class of striatal neurons in Huntington's disease. Science 230, 561-563.
22. Ferrante R. J., Gutekunst C. A., Persichetti F., McNeil S. M., Kowall N. W., Gusella J. F., MacDonald M. E., Beal M. F., and Hersch S. M. (1997) Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J. Neurosci. 17, 3052-3063.
23. Ghasemzadeh M. B., Sharma S., Surmeier D. J., Eberwine J. H., and Chesselet M.-F. (1996) Multiplicity of glutamate receptor subunits in single striatal neurons: an RNA amplification study. Mol. Pharmacol. 49, 852-859.
24. Goldberg Y. P., Kalchman M. A., Metzler M., Nasir J., Zeisler J., Graham R., Koide H. B., O'Kusky J., Sharp A. H., Ross C. A., Jirik F., and Hayden M. R. (1996a) Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript. Hum. Mol. Genet. 5, 177-183.
25. Goldberg Y. P., Nicholson D. W., Rasper D. M., Kalchman M. A., Koide H. B., Graham R. K., Bromm M., Kazemi-Esfarjani P., Thornberry N. A., Baillancourt J. P., and Hayden M. R. (1996b) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat. Genet. 13, 442-449.
26. Gutekunst C. A., Levey A. I., Heilman C. J., Whaley W. L., Yi H., Nash N. R., Rees H. D., Madden J. J., and Hersch S. M. (1995) Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc. Natl. Acad. Sci. USA 92, 8710-8714.
27. Hackam A. S., Singaraja R., Wellington C. L., Metzler M., McCutcheon K., Zhang T., Kalchman M., and Hayden M. R. (1998) The influence of huntingtin protein size on nuclear localization and cellular toxicity. J. Cell Biol. 141, 1097-1105.
28. Hantraye P., Riche D., Maziere M., and Isacson O. (1990) A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon. Exp. Neurol. 108, 91-104.
29. Harper P. S., ed (1991) Huntington's Disease, 2nd edit. W. B. Saunders, London.
30. Hollmann M. and Heinemann S. (1994) Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31-108.
31. Huettner J. E. and Bean B. P. (1988) Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc. Natl. Acad. Sci. USA 85, 1307-1311.
32. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
33. Isaac J. T., Nicoll R. A., and Malenka R. C. (1995) Evidence for silent synapses: implications for the expression of LTP. Neuron 15, 427-434.
34. Jahr C. E. (1992) High probability opening of NMDA receptor channels by L-glutamate. Science 255, 470-472.
35. Kalchman M. A., Koide H. B., McCutcheon K., Graham R. K., Nichol K., Nishiyama K., Kazemi-Esfarjani P., Lynn F. C., Wellington C., Metzler M., Goldberg Y. P., Kanazawa I., Gietz R. D., and Hayden M. R. (1997) HIP1, a human homolog of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nat. Genet. 16, 44-53.
36. Keller J. N., Guo Q., Holtsberg F. W., Bruce-Keller A. J., and Mattson M. P. (1998) Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J. Neurosci. 18, 4439-4450.
37. Kim E., Cho K.-O., Rothschild A., and Sheng M. (1996) Heteromultimerization and NMDA receptor-clustering activity of chapsyn110, a member of the PSD-95 family of proteins. Neuron 17, 103-113.
38. Kornau H.-C., Schenker L. T., Kennedy M. B., and Seeburg P. H. (1995) Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269, 1737-1740.
39. Landwehrmeyer G. B., Standaert D. G., Testa C. M., Penney J. B., and Young A. B. (1995) NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. Neuroscience 15, 5297-5307.
40. Li S.-H. and Li X.-J. (1998) Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. Hum. Mol. Genet. 7, 777-782.
41. Li S.-H., Schilling G., Young W. S. III, Li X.-J., Margolis R. L., Stine O. C., Wagster M. V., Abbott M. H., Franz M. L., Ranen N. G., Folstein S. E., Hedreen J. C., and Ross C. A. (1993) Huntington's disease gene (IT15) is widely expressed in human rat tissues. Neuron 11, 985-993.
42. Li X.-J., Li S.-H., Sharp A. H., Nucifora F. C. Jr., Schilling G., Lanahan A., Worley P., Snyder S. H., and Ross C. A. (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378, 398-402.
43. Liao D., Hessler N. A., and Malinow R. (1995) Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slice. Nature 375, 400-404.
44. Martindale D., Hackam A., Wieczorek A., Ellerby L., Wellington C., McCutcheon K., Singaraja R., Kazemi-Esfarjani P., Devon R., Kim S. U., Bredesen D. E., Tufaro F., and Hayden M. R. (1998) Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat. Genet. 18, 150-154.
45. Monaghan D. T., Bridges R. J., and Cotman C. W. (1989) The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 29, 365-402.
46. Mori H., Manabe T., Watanabe M., Satoh Y., Suzuki N., Toki S., Nakamura K., Yagi T., Kushiya E., Takahashi T., Inoue Y., Sakimura K., and Mishina M. (1998) Role of the carboxy-terminal region of the GluRε2 subunit in synaptic localization of the NMDA receptor channel. Neuron 21, 571-580.
47. Müller B. M., Kistner U., Kindler S., Chung W. J., Kuhlendahl S., Fenster S. D., Lau L.-F., Veh R. W., Huganir R. L., Gundelfinger E. D., and Garner C. C. (1996) SAP102, a novel postsynaptic protein that interacts with NMDA receptor complexes in vivo. Neuron 17, 255-265.
48. +-ATPase of Saccharomyces cerevisiae. J. Biol. Chem. 270, 375-443.
49. Nasir J., Floresco S. B., O'Kusky J. R., Diewert V. M., Richman J. M., Zeisler J., Borowski A., Marth J. D., Phillips A. G., and Hayden M. R. (1995) Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81, 811-823.
50. O'Brien R. J., Lau L.-F., and Huganir R. L. (1998) Molecular mechanisms of glutamate receptor clustering at excitatory synapses. Curr. Opin. Neurobiol. 8, 364-369.
51. 2+. Neuron 15, 1109-1120.
52. Portera-Cailliau C., Hedreen J. C., Price D. L., and Koliatsos V. E. (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15, 3775-3787.
53. Raths S., Rohrer J., Crausaz F., and Riezman H. (1993) end3 and end4: two mutants defective in receptor-mediated and fluid-phase endocytosis in Saccharomyces cerevisiae. J. Cell Biol. 120, 55-65.
54. Raymond L. A., Moshaver A., Tingley W. G., and Huganir R. L. (1996) Glutamate receptor ion channel properties predict vulnerability to cytotoxicity in a transfected nonneuronal cell line. Mol. Cell. Neurosci. 7, 102-115.
55. Rigby M., Le Bourdelles B., Heavens R. P., Kelly S., Smith D., Butler A., Hammans R., Hills R., Xuereb J. H., Hill R. G., Whiting P. J., and Sirinathsinghji D. J. S. (1996) The messenger RNAs for the N-methyl-D-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain. Neuroscience 73, 429-497.
56. Rosenmund C. and Westbrook G. L. (1993a) Calcium-induced actin depolymerization reduces NMDA channel activity. Neuron 10, 805-814.
57. 2+ and ATP. J. Physiol. (Lond.) 470, 705-729. [Published erratum appears in J. Physiol. (Lond.) 1994; 475, 547-548.]
58. Rosenmund C., Stern-Bach Y., and Stevens C. F. (1998) The tetrameric structure of a glutamate receptor channel. Science 280, 1596-1599.
59. Sanberg P. R., Calderon S. F., Giordano M., Tew J. M., and Norman A. B. (1989) The QA model of Huntington's disease: locomotor abnormalities. Exp. Neurol. 105, 45-53.
60. Saudou F., Finkbeiner S., Devys D., and Greenberg M. E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66.
61. Scherzinger E., Lurz R., Turmaine M., Mangiarini L., Hollenbach B., Hasenbank R., Bates G.P., Davies S.W., Lehrach H., and Wanker E. E. (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549-558.
62. Sharp A. H., Loev S. J., Schilling G., Li S.-H., Li X.-J., Bao J., Wagster M. V., Kotzuk J. A., Steiner J. P., Lo A., Hedreen J., Sisodia S., Snyder S. H., Dawson T. M., Ryugo D. K., and Ross C. A. (1995) Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14, 1065-1074.
63. Sprengel R., Suchanek B., Amico C., Brusa R., Burnashev N., Rozov A., Hvalby O., Jensen V., Paulsen O., Andersen P., Kim J. J., Thompson R. F., Sun W., Webster L. C., Grant S. G. N., Eilers J., Konnerth A., Li J., McNamara J. O., and Seeburg P. H. (1998) Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. Cell 92, 279-289.
64. Vonsattel J. P., Meyers R. H., Stevens T. J., Ferrante R. J., Bird E. D., and Richardson E. P. Jr. (1985) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577.
65. Wanker E. E., Rovira C., Scherzinger E., Hasenbank R., Walter S., Tait D., Colicelli J., and Lehrach H. (1997) HIP-1: a huntingtin interacting protein isolated by the yeast two-hybrid system. Hum. Mol. Genet. 6, 487-495.
66. Wellington C. L., Ellerby L. M., Hackam A. S., Margolis R. L., Trifiro M. A., Singararja R., McCutcheon K., Salvesen G. S., Propp S. S., Bromm M., Rowland K. J., Zhang T., Rasper D., Roy S., Thornberry N., Pinsky L., Kakizuka A., Ross C. A., Nicholson D. W., Bredesen D. E., and Hayden M. R. (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273, 9158-9167.
67. White J. K., Auerbach W., Duyao M. P., Vonsattel J. P., Gusella J. E., Joyner A. L., and MacDonald M. E. (1997) Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat. Genet. 17, 404-410.
68. Wood J. D., MacMillan J. C., Harper P. S., Lowenstein P. R., and Jones A. L. (1996) Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human, mouse and rat brain. Hum. Mol. Genet. 5, 418-487.
69. Wyszynski M., Lin J., Rao A., Nigh E., Beggs A. H., Craig A. M., and Sheng M. (1997) Competitive binding of α-actinin and calmodulin to the NMDA receptor. Nature 385, 439-442.
70. Young A. B., Greenamyre J. T., Hollingsworth Z., Albin R., D'Amato C., Shoulson I., and Penney J. B. (1988) NMDA receptor losses in putamen from patients with Huntington's disease. Science 241, 981-983.
71. Zeitlin S., Liu J.-P., Chapman D. L., Papaioannou V. E., and Efstratiadis A. (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat. Genet. 11, 155-163.